BIM
JNP

Bogle Investment Management’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Bogle Investment Management’s Portfolio JNP Stock Details JNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-59,756
Closed -$434K – 391
2013
Q3 		$434K Buy
+59,756
New +$402K 0.04% 277

Other funds holding JNP

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return

Bogle Investment Management's JNP Position: Q4 2013 in Review

Bogle Investment Management sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q4 2013, closing a stake of 59,756 shares — an estimated $434K sold.

Bogle Investment Management first reported a position in JNP in Q3 2013 and held it in 1 quarter. The position peaked at $434K in Q3 2013. 31 funds tracked by Wall St. Rank hold JNP as of Q4 2013.

  • Bogle Investment Management reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • Bogle Investment Management sold 59,756 Juniper Pharmaceuticals, Inc. Common Stock shares in Q4 2013, an estimated $434K.
  • Bogle Investment Management first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q3 2013 and held it in 1 quarter.
  • Bogle Investment Management's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $434K in Q3 2013.
  • 31 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q4 2013.

Based on Bogle Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.